Tag Archives: AURAS-AF

Anticoagulant treatment after intracerebral haemorrhage in patients with AF Anticoagulant treatment may be initiated seven to eight weeks after intracerebral haemorrhage (ICH) in patients with atrial fibrillation (AF), to optimise the benefit from treatment and minimise risk, according to a nationwide observational study published recently in Stroke.1 The study aimed to provide observational data on the relationship between the timing of antithrombotic treatment and the competing risks of severe thrombotic and haemorrhagic events in a cohort of Swedish patients with AF and ICH. Patients with AF and a first-ever ICH were identified in the Swed